LTFS
MBVX

Ladenburg Thalmann Financial Services’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MBVX Stock Details MBVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2
Closed – – 5498
2018
Q2 		$0 Hold
2
– – ﹤0.01% 5217
2018
Q1 		$0 Hold
2
– – ﹤0.01% 5305
2017
Q4 		$0 Hold
2
– – ﹤0.01% 5216
2017
Q3 		$0 Hold
2
– – ﹤0.01% 5123
2017
Q2 		$0 Hold
2
– – ﹤0.01% 5064
2017
Q1 		$0 Hold
2
– – ﹤0.01% 5069
2016
Q4 		$0 Hold
2
– – ﹤0.01% 5035
2016
Q3 		$0 Buy
+2
New +$30 ﹤0.01% 4953

Other funds holding MBVX

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MBVX Position: Q3 2018 in Review

Ladenburg Thalmann Financial Services sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q3 2018, closing a stake of 2 shares.

Ladenburg Thalmann Financial Services first reported a position in MBVX in Q3 2016 and held it in 8 quarters. The position peaked at $0 in Q2 2018. 2 funds tracked by Wall St. Rank hold MBVX as of Q3 2018.

  • Ladenburg Thalmann Financial Services reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q3 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 2 MABVAX THERAPEUTICS HLDGS INC shares in Q3 2018.
  • Ladenburg Thalmann Financial Services first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q3 2016 and held it in 8 quarters.
  • Ladenburg Thalmann Financial Services's MABVAX THERAPEUTICS HLDGS INC position peaked at $0 in Q2 2018.
  • 2 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q3 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2018, filed 14 Nov 2018.